Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Cara’s Phase III Success In CKD-Pruritus Puts NDA Filing In Sight
May 29 2019
•
By
Joseph Haas
Itching related to CKD is an unmet medical need with no current approved drug therapy
(Shutterstock)
More from Clinical Trials
More from R&D